The oral Multi-target Tumor Growth Inhibitor™, Zk 304700, inhibits growth of pancreatic neuroendocrine tumors in an orthotopic mouse model

被引：0
|
作者：
Scholz, Arne
Wagner, Karola
Welzel, Martina
Wiedenmann, Bertram
Rosewicz, Stefan
Siemeister, Gerhard
Detjen, Katharina M.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [1] The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model
    Scholz, A.
    Wagner, K.
    Welzel, M.
    Remlinger, F.
    Wiedenmann, B.
    Siemeister, G.
    Rosewicz, S.
    Detjen, K. M.
    [J]. GUT, 2009, 58 (02) : 261 - 270
  • [2] ZK 304709, the oral multi-target tumor growth inhibitor tm, inhibits primary tumor growth and metastasis formation in pancreatic tumor xenograft models.
    Siemeister, G
    Detjen, K
    Hennekes, H
    Kaekoenen, S
    Scholz, A
    Wagner, K
    Wiedenmann, B
    Bosslet, K
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9111S - 9112S
  • [3] The antitumor and antimetastasis effect of the oral Multi-target Tumor Growth Inhibitor™, ZK 304709, in pancreatic tumor xenografts
    Siemeister, Gerhard
    Detjen, Katharina
    Kaekoenen, Sanna-Maria
    Luecking, Ulrich
    Mumberg, Domink
    Scholz, Arne
    Wagner, Karola
    Wiedenmann, Bertram
    Bosslet, Klaus
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [4] ZK 304709, the multi-target tumor growth Inhibitor™ (MTGI™), inhibits osteolysis and tumor burden in a breast cancer bone metastasis model.
    Käkönen, S.
    Bosslet, K.
    Siemeister, G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S28 - S28
  • [5] Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709
    Siemeister, G.
    Luecking, U.
    Wagner, C.
    Detjen, K.
    Mc Coy, C.
    Bosslet, Klaus
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (06) : 269 - 272
  • [6] A molecular pathway inhibitor that inhibits tumor growth in an orthotopic model of invasive pancreatic cancer
    Cashman, John
    Okolotowicz, Karl
    Cheng, Jiongjia
    Lowy, Andrew M.
    Mercola, Mark
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 57 - 58
  • [7] Synergistic effects on tumor growth inhibition by the combination of ZK 304709, the Multi-target Tumor Growth Inhibitor™, and paclitaxel or 5-FU in a mammary tumor xenograft model
    Kaekoenen, Sanna-Maria
    McCoy, Candice
    Hyman, Debra
    Luecking, Ulrich
    Bosslet, Klaus
    Siemeister, Gerhard
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [8] Curcumin Inhibits Tumor Growth and Angiogenesis in an Orthotopic Mouse Model of Human Pancreatic Cancer
    Bimonte, Sabrina
    Barbieri, Antonio
    Palma, Giuseppe
    Luciano, Antonio
    Rea, Domenica
    Arra, Claudio
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [9] Reconstitution of p16INK4a in an orthotopic pancreatic mouse model inhibits tumor growth and angiogenesis
    Schulz, Petra
    Scholz, Arne
    Rexin, Annett
    Hauff, Peter
    Schirner, Michael
    Wiedenmann, Bertram
    Detjen, Katharina
    Rosewicz, Stefan
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A35 - A35
  • [10] Nrf2 modulates pancreatic tumor growth in the orthotopic mouse model
    Stopa, K.
    Ferdek, P.
    Kusiak, A.
    Werner, E.
    Hajduk, K.
    Stepniewski, J.
    Kachamakova-Trojanowska, N.
    Paciorek, M.
    Jozkowicz, A.
    Jakubowska, M.
    [J]. FEBS OPEN BIO, 2019, 9 : 356 - 356
12345